An individualized cirrhosis screening strategy might be more cost-effective in the general population. Zhao S, Liao X, Fan R. J Hepatol 2022 Jul 14. pii: S0168-8278(22)02937.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Zhao S, Liao X, Fan R. An individualized cirrhosis screening strategy might be more cost-effective in the general population. J Hepatol 2022 Jul 14. pii: S0168-8278(22)02937.
PMID: 35843376